Bioheart, Inc. , a biotechnology company focused on the discovery, development and, subject to United States regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announces partnership to bring Bioheart regenerative therapies to Colombia. Global Stem Cells Group, Inc. and Bioheart have partnered with Stemlab to introduce regenerative medicine to the more than 48 million people living in Colombia.
http://ift.tt/1wHXVr2
http://ift.tt/1wHXVr2
No comments:
Post a Comment